Upcoming Appearances

November 1, 2016: Matt Seidner, CTAF Program Manager, will present ICER’s report on diabetes prevention programs at the Massachusetts Department of Public Health’s Diabetes Prevention Summit in Westborough, MA.

November 4, 2016: Dan Ollendorf, PhD, ICER’s Chief Scientific Officer, will participate in a panel on integrating value-based assessment into alternative financing options at Harvard School of Public Health Leadership Council meeting in Boston, MA.

November 4, 2016: Steve Pearson, MD, MSc, President of ICER, will speak on a panel titled “What is Value?” at the Biopharma Congress in Washington, DC.

November 4, 2016: Sarah Emond, MPP, ICER’s Chief Operating Officer, will participate in a panel titled “Drug Pricing, Clinical Effectiveness, and the Need for Transparency” at the New Hampshire Insurance Department Annual Public Hearing on Health Insurance Premiums in Concord, NH.

November 4, 2016: Rick Chapman, PhD, MS, ICER’s Director of Health Economics, will participate in a panel titled “What Value Means to Me: Patient Perspectives in the Development of Value Assessment Frameworks” at the BIO Patient and Health Advocacy Summit in Washington, DC.

November 10, 2016: Steve Pearson will present on “Drug Pricing and Reimbursement” at the Harvard Business School Healthcare Alumni Annual Meeting  in Boston, MA.

November 14, 2016: Steve Pearson will speak on a panel titled  “Value and Quality — Redirecting the Value Conversation: How do Patients and Families Define Cost and Benefit?” at the National Patient Advocate Foundation Fall Policy Consortium in Washington, DC.

November 16, 2016: Steve Pearson will speak on “Value Frameworks in Cancer Care and the Role of Modeling to Inform Drug Pricing” at the 2016 Annual Meeting of the Cancer Intervention and Surveillance Modeling Network (CISNET) in Rockville, MD.

November 18, 2016: Sarah Emond will participate on a panel titled, “What Are the Cost Drivers & Solutions for Reform?” at the Massachusetts Association of Health Plans Annual Health Policy Conference in Boston, MA.

November 30, 2016: Steve Pearson will speak on “The Future of Specialty Drugs: Treatment and Affordability” at the West Coast Healthcare Executive Summit, Newport Beach, CA.

Key Dates

November 4th: Psoriasis Evidence Report Posted

November 7th: Atopic Dermatitis Draft Scoping Document Posted

  • November 7th– November 28th: Public Comment Period

November 18th: New England CEPAC Public Meeting on Treatments for Plaque Psoriasis

November 22nd: Draft Evidence Report on Multiple Sclerosis Posted

  • November 22nd– December 21st: Public Comment Period